NPPB and breast cancer: The significant rise in NT-proBNP levels in the control group emphasizes the cardiotoxicity of DOX, which has been associated with cumulative cardiac dysfunction in studies like those conducted by Volkova & Russell on patients with BC receiving DOX-based chemotherapy [50].